Basal Forebrain Cholinergic Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The basal forebrain cholinergic system (BFC) comprises neurons in the medial septum, diagonal band, and nucleus basalis of Meynert. These neurons provide the major cholinergic innervation to the hippocampus and neocortex and are severely affected in Alzheimer's disease. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Exact |
The basal forebrain includes:
These neurons are essential for:
BFC neurons show:
Cholinergic markers are dramatically reduced:
Amyloid-beta impacts cholinergic neurons:
Tau affects BFC neurons through:
Microglial activation:
BFC degeneration contributes to:
Current therapies target this system:
Promising approaches:
Research directions:
The study of Basal Forebrain Cholinergic Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Schliebs & Arendt (2011). Cholinergic system in AD. Journal of Neural Transmission. 2011. ↩︎